Author affiliations: Division of Environmental Health Sciences, School of Public Health, University of California, Berkeley, Berkeley, California (Christine F. Skibola, Danica R. Skibola, Martyn T. Smith, Luoping Zhang, Renee Shiao); Department of Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco, San Francisco, California (Paige M. Bracci, Elizabeth A. Holly); Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany (Alexandra Nieters, Nikolaus Becker); British Columbia Cancer Research Center, Vancouver, British Columbia, Canada (Angela Brooks-Wilson, John J. Spinelli); Department of Biomedical Physiology and Kinesiology, Faculty of Science, Simon Fraser University, Vancouver, British Columbia, Canada (Angela Brooks-Wilson); Unit of Infections and Cancer, Cancer Epidemiology Research Programme, Institut Català d’ Oncologia, Institut d'Investigació Biomèdica de Bellvitge, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, Barcelona, Spain (Silvia de Sanjosé, Yolanda Benavente); Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota (James R. Cerhan, Susan L. Slager, Anne J. Novak); Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland (Qing Lan, Mark Purdue, Anneclaire J. De Roos, Patricia Hartge, Martha S. Linet, Stephen J. Chanock, Nathaniel Rothman); Department of Family Medicine and Public Health Sciences, School of Medicine, Wayne State University, Detroit, Michigan (Maryjean Schenk); Karmanos Cancer Institute, Wayne State University, Detroit, Michigan (Maryjean Schenk); Epidemiology and Genetics Unit, Department of Health Sciences, University of York, York, United Kingdom (Eleanor Kane, Eve Roman, Tracy Lightfoot, Alex Smith); Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California (Wendy Cozen); Department of Epidemiology and Public Health, School of Medicine, Yale University, New Haven, Connecticut (Qing Lan, Tongzhang Zheng, Yawei Zhang, Theodore R. Holford); Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic (Lenka Foretova); International Agency for Research on Cancer, Lyon, France (Paolo Boffetta, Paul Brennan); School of Public Health, University of Sydney, Sydney, New South Wales, Australia (Anne Kricker, Bruce Armstrong, Ann Maree Hughes); Department of Public Health, Occupational Health Section, Institute of Occupational Medicine, University of Cagliari, Cagliari, Italy (Pierluigi Cocco); Registry of Hematological Malignancies, Burgundy University and University Hospital, Dijon, France (Marc Maynadie); School of Nursing, Dublin City University, Dublin, Ireland (Anthony Staines); and Division of Etiology, Department of Population Sciences, City of Hope, Duarte, California (Sophia S. Wang).
Drs. Christine F. Skibola and Paige M. Bracci are joint first authors of this article.
This work was supported by National Institutes of Health (NIH) grant CA104862 (C. F. Skibola, Principal Investigator (PI), University of California, San Francisco (UCSF)/University of California, Berkeley (UCB), studies); NIH grants CA45614, CA89745, and CA87014 (E. A. Holly, PI, UCSF/UCB studies); the National Cancer Institute of Canada, the Canadian Institutes of Health Research, and the Michael Smith Foundation for Health Research (British Columbia study); the Intramural Research Program of the NIH (P. Hartge, PI, National Cancer Institute (NCI)/Surveillance, Epidemiology, and End Results study); the European Commission (grant QLK4-CT-2000-00422, EpiLymph study); NIH contract NO1-CO-12400 (EpiLymph Italy study); Fondazione Cariverona (2004: A. Scarpa, PI, EpiLymph Italy study; 2005: P. S. Moore, PI, EpiLymph Italy study); Compagnia di San Paolo—Programma Oncologia (P. Cocco, PI, EpiLymph Italy study); José Carreras Leukemia Foundation grant DJCLS-R04/08 (A. Nieters, PI, EpiLymph Germany study); Federal Office for Radiation Protection grants StSch4261 and StSch4420 (N. Becker, PI, EpiLymph Germany study); Fondo Investigaciones Sanitarias grant PI040091 (S. de Sanjose, PI, EpiLymph Spain study); Network for Research in Epidemiology and Public Health grant 03/09 and Fondo Investigaciones Sanitarias grant PI041467 (R. Bosch, PI, EpiLymph Spain study); Leukaemia Research Fund (E. Roman, PI, United Kingdom study); the National Health and Medical Research Council of Australia, the Cancer Council New South Wales, and the University of Sydney Medical Foundation Program (B. Armstrong, PI, New South Wales study); the Intramural Research Program of the NCI (New South Wales study); NCI grant CA62 006 and the Intramural Research Program of the NCI (T. Zheng, PI, Yale study); NIH grant CA92153 (J. Cerhan, PI, Mayo Clinic study); the Health Research Board, Ireland (EpiLymph); and Cancer Research, Ireland (InterLymph) (A. Staines, PI, EpiLymph Ireland study).
Conflict of interest: none declared.